FCSC : Summary for Fibrocell Science Inc - Yahoo Finance

U.S. Markets open in 6 hrs.

Fibrocell Science, Inc. (FCSC)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.00+0.02 (+1.01%)
At close: 4:00PM EDT
People also watch
SYNOGENCRMDFATEAPHB
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.98
Open1.98
Bid1.02 x 1400
Ask2.98 x 3500
Day's Range1.93 - 2.00
52 Week Range0.52 - 3.78
Volume26,708
Avg. Volume183,329
Market Cap29.39M
Beta1.72
PE Ratio (TTM)-1.70
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Fibrocell Science, Inc. :FCSC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
    Capital Cube7 days ago

    Fibrocell Science, Inc. :FCSC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis Fibrocell Science, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Fibrocell Science, Inc. – bluebird bio, Inc., Misonix, Inc., TransEnterix, Inc., Biostage, Inc., Organovo Holdings, Inc., Intuitive Surgical, Inc., Bovie Medical Corporation and Alexion Pharmaceuticals, Inc. (BLUE-US, MSON-US, ... Read more (Read more...)

  • Fibrocell Science, Inc. :FCSC-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
    Capital Cube12 days ago

    Fibrocell Science, Inc. :FCSC-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017

    Categories: Yahoo Finance Get free summary analysis Fibrocell Science, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Fibrocell Science, Inc. – bluebird bio, Inc., TransEnterix, Inc., Biostage, Inc., Organovo Holdings, Inc., Intuitive Surgical, Inc., Bovie Medical Corporation and Alexion Pharmaceuticals, Inc. (BLUE-US, TRXC-US, BSTG-US, ONVO-US, ... Read more (Read more...)

  • GlobeNewswire17 days ago

    Fibrocell Announces One-for-Three Reverse Stock Split

    EXTON, Pa., March 10, 2017-- Fibrocell Science, Inc., a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that it ...